Deerfield Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,447,331
Closed -$34.3M 168
2025
Q3
$34.3M Buy
4,447,331
+2,299,331
+107% +$16.1M 0.52% 44
2025
Q2
$15.7M Buy
+2,148,000
New +$17.3M 0.29% 58
2024
Q4
Sell
-9,486
Closed -$140K 309
2024
Q3
$140K Sell
9,486
-25,184
-73% -$394K ﹤0.01% 432
2024
Q2
$481K Buy
+34,670
New +$492K 0.01% 267

Other funds holding NEO

Deerfield Management's NEO Position: Q4 2025 in Review

Deerfield Management sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 4,447,331 shares — an estimated $34.3M sold.

Deerfield Management first reported a position in NEO in Q2 2024 and held it in 4 quarters. The position peaked at $34.3M in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Deerfield Management reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Deerfield Management sold 4,447,331 NeoGenomics shares in Q4 2025, an estimated $34.3M.
  • Deerfield Management first reported a position in NeoGenomics in Q2 2024 and held it in 4 quarters.
  • Deerfield Management's NeoGenomics position peaked at $34.3M in Q3 2025.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Deerfield Management's 13F filing for Q4 2025, filed 17 Feb 2026.